STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Abigail P. Johnson and FMR Report 14.5% Stake in Immuneering (IMRX)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

FMR LLC and Abigail P. Johnson reported beneficial ownership of 8,787,052 shares of Immuneering Corp Class A common stock, representing 14.5% of the class as of 09/30/2025. The filing shows FMR LLC holds 8,780,283 shares with sole voting power and 8,787,052 shares with sole dispositive power, while Abigail P. Johnson is reported with sole dispositive power for the same 8,787,052 shares.

The filing discloses that the Fidelity Growth Company Commingled Pool held 3,317,460 shares, or 5.5% of the class, at the same date. Signatures attest the holdings were acquired in the ordinary course of business and not for the purpose of changing control.

Positive

  • Material stake disclosed: 8,787,052 shares represent 14.5% of Class A stock
  • Clear voting/dispositive details: FMR LLC reports sole voting power on 8,780,283 shares and sole dispositive power on 8,787,052
  • Transparency on pooled holdings: Fidelity Growth Company Pool holds 3,317,460 shares (5.5%)

Negative

  • None.

Insights

Large passive stake: 8.79M shares (14.5%) signals meaningful institutional exposure.

The reported 8,787,052 shares equal 14.5% of Class A stock, a concentration that can affect liquidity and shareholder composition.

Dependencies include whether holdings are passive or part of actively managed sleeves; the filing states the position is held in the ordinary course of business. Monitor quarterly filings for changes within one quarter to one year.

Beneficial ownership by a voting-control capable entity and an individual requires governance monitoring.

The cover page shows FMR LLC with sole voting power for 8,780,283 shares and Abigail P. Johnson with sole dispositive power for 8,787,052 shares; both report the same aggregate stake of 14.5%.

Watch for any related-party actions or changes in voting intent disclosed in future filings over the next few quarters; the filing affirms no current intent to change control.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:10/06/2025
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:10/06/2025

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What stake did FMR LLC and Abigail P. Johnson report in IMRX?

They reported beneficial ownership of 8,787,052 shares, equal to 14.5% of Class A common stock as of 09/30/2025.

How many shares does FMR LLC have voting power over in IMRX?

FMR LLC reports sole voting power over 8,780,283 shares and sole dispositive power over 8,787,052 shares.

Does Abigail P. Johnson hold voting power for the reported IMRX shares?

The filing shows Abigail P. Johnson with 0 sole voting power but with sole dispositive power over 8,787,052 shares.

Did the filing say the holdings aim to change company control?

No; the certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What portion of IMRX did the Fidelity Growth Company Pool own?

The Fidelity Growth Company Commingled Pool owned 3,317,460 shares, or 5.5% of Class A common stock at 09/30/2025.
Immuneering Corp

NASDAQ:IMRX

IMRX Rankings

IMRX Latest News

IMRX Latest SEC Filings

IMRX Stock Data

431.97M
53.02M
21.08%
9.24%
4.29%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE